[Monogenic heart disease]

Jost Schönberger1, Georg Ertl

  • 1Medizinische Klinik und Poliklinik I/ Herzkreislauf-Zentrum und Institut für Klinische Biochemie und Pathobiochemie, Universität Würzburg, Josef-Schneider-Strasse 2, Würzburg. j.schoenberger@medizin.uni-wuerzburg.de

Medizinische Klinik (Munich, Germany : 1983)
|March 18, 2008
PubMed

Insights

Most cardiovascular diseases have complex causes, but some single-gene (monogenic) disorders offer insights into genetic defects and pathophysiology. Understanding these genetic factors aids in personalized risk assessment and medical care for affected families.

Area of Science:

  • Cardiovascular Science
  • Genetics
  • Pathophysiology

Context:

  • Cardiovascular disorder pathogenesis is typically multifactorial, involving genetic, nutritional, and environmental factors.
  • A subset of cardiovascular diseases exhibits Mendelian traits, stemming from single gene defects.
  • Even monogenic cardiovascular diseases show variable expressivity, indicating the presence of modifying factors.

Purpose:

  • To explore the genetic underpinnings of cardiovascular diseases, particularly monogenic forms.
  • To understand the role of genetic defects in cardiovascular pathophysiology.
  • To highlight the utility of genetic diagnostics in managing inherited cardiovascular conditions.

Summary:

  • While most cardiovascular diseases are complex, monogenic disorders like familial cardiomyopathies provide clear examples of single gene defects.
  • Investigating these monogenic conditions reveals underlying genetic causes and aids in understanding disease mechanisms.
  • Modifying factors influence disease penetrance even in monogenic cardiovascular diseases.
  • Genetic diagnostics enable personalized medical care by assessing individual risks in offspring.

Impact:

  • Identification of specific genetic defects in monogenic cardiovascular diseases deepens our understanding of pathophysiology.
  • Predictive genetic diagnostics allow for tailored medical management based on individual risk profiles.
  • This research contributes to advancing precision medicine in the field of cardiology.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...